DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Tazdait M, Mezquita L, Lahmar J. et al.
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.
Eur J Cancer 2018;
88: 38-47
DOI: 10.1016/j.ejca.2017.10.017. (PMID: 29182990)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.